You make discoveries. We’ll make them into products.
Patheon works with hundreds of emerging pharmaceutical companies to achieve clinical proof of concept. These companies often have limited funding, significant time pressures, and little experience or resources beyond the earliest stages of development. Patheon gives them instant access to all the technologies and expertise required to quickly and cost-efficiently transform their discoveries into viable products.
In order to meet the distinct needs of our emerging pharma clients, Patheon has built facilities dedicated to early development. We have also created unique programs such as SoluPath™, Quick-to-Clinic™, and Patheon Certified Consultants™ that have proven processes in place to overcome the challenges common at this stage. What’s more, they benefit from our decades of experience across the entire drug development process. The formulations we develop accomplish their immediate goals while establishing a scientifically sound foundation for a smooth transition to late development, scale-up and commercial supply.
With expertise amassed from thousands of projects, Patheon works with startups to tailor an efficient preclinical and clinical development program of carefully selected services that balances risk and return, and charts the path to success.